Sintx Technologies (SINT) Shareholder's Equity Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.92% |
| Dec 31, 2025 | -35.28% |
| Sep 30, 2025 | -31.78% |
| Jun 30, 2025 | -26.97% |
| Mar 31, 2025 | -11.48% |
| Dec 31, 2024 | -5.63% |
| Sep 30, 2024 | -1.53% |
| Jun 30, 2024 | 6.55% |
| Mar 31, 2024 | 7.95% |
| Dec 31, 2023 | 0.87% |
| Sep 30, 2023 | 5.73% |
| Jun 30, 2023 | 4.08% |
| Mar 31, 2023 | 21.65% |
| Dec 31, 2022 | 0.94% |
| Sep 30, 2022 | 289.97% |
| Jun 30, 2022 | 296.69% |
| Mar 31, 2022 | 301.16% |
| Dec 31, 2021 | 8.88% |
| Sep 30, 2021 | 10.84% |
| Jun 30, 2021 | 17.10% |
| Dec 31, 2020 | 12.48% |
| Sep 30, 2020 | 78.33% |
| Jun 30, 2020 | 18.66% |
| Mar 31, 2020 | 28.64% |
| Dec 31, 2019 | -5.51% |
| Sep 30, 2019 | -12.80% |
| Jun 30, 2019 | -15.40% |
| Mar 31, 2019 | -19.85% |
| Dec 31, 2018 | 15.49% |